SCOPE: In contrast to well-characterized PUFA levels in serum, little is known regarding their downstream metabolic products. However, many of these compounds are lipid mediators with prominent roles during pro- and antiinflammatory processes. METHODS AND RESULTS: In this double blind crossover study on asthmatics, shifts in serum levels of ω-3 and ω-6 PUFA-derived oxidized fatty acids (e.g. eicosanoids, oxylipins) were quantified following dietary fish oil supplementation. Serum was obtained from subjects following fasting at three occasions; (i) prior to supplementation, (ii) following a 3-week supplement intake of either placebo or fish oil, and (iii) following a 3-week washout period with a subsequent 3-week period of either fish oil or placebo supplement. A total of 87 oxylipins representing cyclooxygenase (COX), lipoxygenase (LOX), and cytochrome P450 (CYP) metabolic pathways were screened via LC-MS/MS. The primary alterations observed were in CYP- and 15-LOX-derived EPA- and CYP-derived DHA oxylipins. CONCLUSION: The results indicate that intake of an ω-3 rich diet alters not only the PUFA ratio, but also the ratio of downstream oxylipins. These data further support that dietary manipulation with ω-3 PUFAs affects not only PUFA levels, but importantly also the downstream metabolic profile.
RCT Entities:
SCOPE: In contrast to well-characterized PUFA levels in serum, little is known regarding their downstream metabolic products. However, many of these compounds are lipid mediators with prominent roles during pro- and antiinflammatory processes. METHODS AND RESULTS: In this double blind crossover study on asthmatics, shifts in serum levels of ω-3 and ω-6 PUFA-derived oxidized fatty acids (e.g. eicosanoids, oxylipins) were quantified following dietary fish oil supplementation. Serum was obtained from subjects following fasting at three occasions; (i) prior to supplementation, (ii) following a 3-week supplement intake of either placebo or fish oil, and (iii) following a 3-week washout period with a subsequent 3-week period of either fish oil or placebo supplement. A total of 87 oxylipins representing cyclooxygenase (COX), lipoxygenase (LOX), and cytochrome P450 (CYP) metabolic pathways were screened via LC-MS/MS. The primary alterations observed were in CYP- and 15-LOX-derived EPA- and CYP-derived DHA oxylipins. CONCLUSION: The results indicate that intake of an ω-3 rich diet alters not only the PUFA ratio, but also the ratio of downstream oxylipins. These data further support that dietary manipulation with ω-3 PUFAs affects not only PUFA levels, but importantly also the downstream metabolic profile.
Authors: Nikolaos Psychogios; David D Hau; Jun Peng; An Chi Guo; Rupasri Mandal; Souhaila Bouatra; Igor Sinelnikov; Ramanarayan Krishnamurthy; Roman Eisner; Bijaya Gautam; Nelson Young; Jianguo Xia; Craig Knox; Edison Dong; Paul Huang; Zsuzsanna Hollander; Theresa L Pedersen; Steven R Smith; Fiona Bamforth; Russ Greiner; Bruce McManus; John W Newman; Theodore Goodfriend; David S Wishart Journal: PLoS One Date: 2011-02-16 Impact factor: 3.240
Authors: Robert Fischer; Anne Konkel; Heidrun Mehling; Katrin Blossey; Andrej Gapelyuk; Niels Wessel; Clemens von Schacky; Ralf Dechend; Dominik N Muller; Michael Rothe; Friedrich C Luft; Karsten Weylandt; Wolf-Hagen Schunck Journal: J Lipid Res Date: 2014-03-16 Impact factor: 5.922
Authors: James F Markworth; Gunveen Kaur; Eliza G Miller; Amy E Larsen; Andrew J Sinclair; Krishna Rao Maddipati; David Cameron-Smith Journal: FASEB J Date: 2016-07-26 Impact factor: 5.191
Authors: Emmanuel Akintoye; Jason H Y Wu; Tao Hou; Xiaoling Song; Jun Yang; Bruce Hammock; Dariush Mozaffarian Journal: J Lipid Res Date: 2016-01-09 Impact factor: 5.922
Authors: Nils Helge Schebb; Annika I Ostermann; Jun Yang; Bruce D Hammock; Andreas Hahn; Jan Philipp Schuchardt Journal: Prostaglandins Other Lipid Mediat Date: 2014-05-29 Impact factor: 3.072
Authors: Romain A Colas; Masakazu Shinohara; Jesmond Dalli; Nan Chiang; Charles N Serhan Journal: Am J Physiol Cell Physiol Date: 2014-04-02 Impact factor: 4.249
Authors: Jan Philipp Schuchardt; Inga Schneider; Ina Willenberg; Jun Yang; Bruce D Hammock; Andreas Hahn; Nils Helge Schebb Journal: Prostaglandins Other Lipid Mediat Date: 2014-03-22 Impact factor: 3.072